Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2025-12-24 @ 7:49 PM
NCT ID:
NCT02427503
Eligibility Criteria:
Inclusion Criteria:
* Patients of both sexes aged ≥ 18 and younger than 70 years diagnosed with persistent asthma (according to GEMA4.0 criteria) (18) and grade II and III bilateral sinonasal polyposis of Lildholdlt (9,19), which, as indicated in routine clinical practice established by an otolaryngologist, will undergo FESS.
Exclusion Criteria:
* Intermittent asthma;
* exacerbation of asthma that required treatment with parenteral steroids one month prior to visit 1;
* concomitance of other chronic respiratory diseases (bronchiectasis, fibrosis, etc.);
* other disabling severe comorbidities in the opinion of the investigators;
* previous noninflammatory sinonasal pathology;
* corticosteroid-dependent patients or managed with other immunomodulatory treatments.
* Patients with a history of previous nasal surgery.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02427503
Study Brief:
Protocol Section:
NCT02427503